Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Disclosure of interest: no E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2551 - ESOC25-1989 RISK FACTORS AND PREDICTION MODEL OF RECURRENT STROKE FOR PATIENTS WITH SYMPTOMATIC INTRACRANIAL ARTERIAL STENOSIS AND TREATED WITH MEDICAL THERAPY Yixin Sun 1,2 , Ruofan Li 3 , Eyad Almallouhi 4 , Tao Wang 5 , Jie Wang 5 , Jichang Luo 5 , Colin P Derdeyn 6 , Liqun Jiao 5 1 Department of Neurosurgery, Xuanwu Hospital, Beijing, China, 2 Eight-year-program, Grade 2018, Peking Unversity First Hospital, Beijing, China, 3 Health Science Center, Peking University, Beijing, China, 4 Departments of Neurology and Neurosurgery, Medical University of South Carolina, Charleston, United States, 5 Capital Medical University Xuanwu Hospital, Beijing, China, 6 Departments of Radiology and Neurology, University of Iowa Hospitals and Clinics, Iowa City, United States Background and Aims: Intracranial atherosclerosis is a common cause of stroke, with a high risk of recurrent stroke
Oral bioavailability in humans remains an assumption
Methylation touches gene expression broadly, so pushing on it nonstop and indefinitely isnt something to do casually
Treatment reduces circulating markers of metabolic dysfunction and inflammation, creating a more favorable metabolic environment that supports insulin sensitivity and glucose regulation
